Tech Company Financing Transactions
Vividion Therapeutics Funding Round
On 3/6/2018, Vividion Therapeutics announced funding from Celgene.
Transaction Overview
Company Name
Announced On
3/6/2018
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Celgene (Rupert Vessey)
Proceeds Purpose
The multi-year collaboration is focused on the identification and development of unique small molecules against targets for a range of oncology, inflammatory and neurodegenerative indications. The collaboration is intended to advance new small molecules that function through the ubiquitin proteasome system, modulating specific protein levels for therapeutic benefit.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
5820 Nancy Ridge Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Vividion Therapeutics is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide ligand and target discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Hatfield
Chief Financial Officer
Patty Allen
Chief Scientific Officer
Robert Abraham
Browse more venture capital transactions:
Prev: 3/6/2018: Paro venture capital transaction
Next: 3/6/2018: Starcity venture capital transaction
Share this article
About Our VC Transactions Data
We report on every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs